121 related articles for article (PubMed ID: 11427261)
1. A recombinant Semliki Forest virus particle vaccine encoding the prME and NS1 proteins of louping ill virus is effective in a sheep challenge model.
Morris-Downes MM; Sheahan BJ; Fleeton MN; Liljeström P; Reid HW; Atkins GJ
Vaccine; 2001 Jul; 19(28-29):3877-84. PubMed ID: 11427261
[TBL] [Abstract][Full Text] [Related]
2. Recombinant Semliki Forest virus particles encoding the prME or NS1 proteins of louping ill virus protect mice from lethal challenge.
Fleeton MN; Sheahan BJ; Gould EA; Atkins GJ; Liljestr M P
J Gen Virol; 1999 May; 80 ( Pt 5)():1189-1198. PubMed ID: 10355766
[TBL] [Abstract][Full Text] [Related]
3. Recombinant Semliki Forest virus particles expressing louping ill virus antigens induce a better protective response than plasmid-based DNA vaccines or an inactivated whole particle vaccine.
Fleeton MN; Liljeström P; Sheahan BJ; Atkins GJ
J Gen Virol; 2000 Mar; 81(Pt 3):749-58. PubMed ID: 10675413
[TBL] [Abstract][Full Text] [Related]
4. Recombinant Semliki Forest virus vector exhibits potential for avian virus vaccine development.
Phenix KV; Wark K; Luke CJ; Skinner MA; Smyth JA; Mawhinney KA; Todd D
Vaccine; 2001 Apr; 19(23-24):3116-23. PubMed ID: 11312006
[TBL] [Abstract][Full Text] [Related]
5. Self-replicative RNA vaccines elicit protection against influenza A virus, respiratory syncytial virus, and a tickborne encephalitis virus.
Fleeton MN; Chen M; Berglund P; Rhodes G; Parker SE; Murphy M; Atkins GJ; Liljeström P
J Infect Dis; 2001 May; 183(9):1395-8. PubMed ID: 11294672
[TBL] [Abstract][Full Text] [Related]
6. Vaccinia virus recombinant expressing gene of tick-borne encephalitis virus non-structural NS1 protein elicits protective activity in mice.
Khoretonenko MV; Vorovitch MF; Zakharova LG; Pashvykina GV; Ovsyannikova NV; Stephenson JR; Timofeev AV; Altstein AD; Shneider AM
Immunol Lett; 2003 Dec; 90(2-3):161-3. PubMed ID: 14687719
[TBL] [Abstract][Full Text] [Related]
7. Semliki Forest virus-based vaccines: persistence, distribution and pathological analysis in two animal systems.
Morris-Downes MM; Phenix KV; Smyth J; Sheahan BJ; Lileqvist S; Mooney DA; Liljeström P; Todd D; Atkins GJ
Vaccine; 2001 Feb; 19(15-16):1978-88. PubMed ID: 11228368
[TBL] [Abstract][Full Text] [Related]
8. Immunization with recombinant vaccinia viruses expressing structural and part of the nonstructural region of tick-borne encephalitis virus cDNA protect mice against lethal encephalitis.
Dmitriev IP; Khromykh AA; Ignatyev GM; Gainullina MN; Ageenko VA; Dryga SA; Vorobyeva MS; Sandakhchiev LS
J Biotechnol; 1996 Jan; 44(1-3):97-103. PubMed ID: 8717392
[TBL] [Abstract][Full Text] [Related]
9. [A comparison of the immune response induced by DNA or by an inactivated vaccine against tick-borne encephalitis].
Morozova OV; Popova RV; Maksimova TG; Mitrofanova EE; Bakhvalova VN
Zh Mikrobiol Epidemiol Immunobiol; 2000; (2):54-7. PubMed ID: 10808575
[TBL] [Abstract][Full Text] [Related]
10. Immunological basis for protection in a murine model of tick-borne encephalitis by a recombinant adenovirus carrying the gene encoding the NS1 non-structural protein.
Timofeev AV; Ozherelkov SV; Pronin AV; Deeva AV; Karganova GG; Elbert LB; Stephenson JR
J Gen Virol; 1998 Apr; 79 ( Pt 4)():689-95. PubMed ID: 9568962
[TBL] [Abstract][Full Text] [Related]
11. Innate and adaptive immune responses to tick-borne flavivirus infection in sheep.
Mansfield KL; Johnson N; Banyard AC; Núñez A; Baylis M; Solomon T; Fooks AR
Vet Microbiol; 2016 Mar; 185():20-8. PubMed ID: 26931387
[TBL] [Abstract][Full Text] [Related]
12. A novel recombinant adenovirus vector expressing a flavivirus non-structural protein protects against lethal flavivirus challenge.
Jacobs SC
Clin Sci (Lond); 1993 Aug; 85(2):117-22. PubMed ID: 8403779
[No Abstract] [Full Text] [Related]
13. Tick-borne encephalitis virus NS3 gene expression does not protect mice from homologous viral challenge.
Morozova OV; Maksimova TG; Bakhvalova VN
Viral Immunol; 1999; 12(4):277-80. PubMed ID: 10630787
[TBL] [Abstract][Full Text] [Related]
14. Tick-borne encephalitis virus and louping-ill virus may co-circulate in Southern Norway.
Ytrehus B; Vainio K; Dudman SG; Gilray J; Willoughby K
Vector Borne Zoonotic Dis; 2013 Oct; 13(10):762-8. PubMed ID: 23808981
[TBL] [Abstract][Full Text] [Related]
15. [A recombinant adenovirus expressing the NS1 nonstructural protein of tick-borne encephalitis virus: some characteristics of the immunologic basis of antiviral action].
Timofeev AV; Ozherelkov SV; Pronin AV; Deeva AV; Elbert LB; Stefenson JR
Vopr Virusol; 1997; 42(5):219-22. PubMed ID: 9424847
[TBL] [Abstract][Full Text] [Related]
16. Prevalence, spatial distribution and the effect of control measures on louping-ill virus in the Forest of Bowland, Lancashire.
Laurenson MK; McKendrick IJ; Reid HW; Challenor R; Mathewson GK
Epidemiol Infect; 2007 Aug; 135(6):963-73. PubMed ID: 17346361
[TBL] [Abstract][Full Text] [Related]
17. Tick-borne Langat/mosquito-borne dengue flavivirus chimera, a candidate live attenuated vaccine for protection against disease caused by members of the tick-borne encephalitis virus complex: evaluation in rhesus monkeys and in mosquitoes.
Pletnev AG; Bray M; Hanley KA; Speicher J; Elkins R
J Virol; 2001 Sep; 75(17):8259-67. PubMed ID: 11483771
[TBL] [Abstract][Full Text] [Related]
18. Chimeric Langat/Dengue viruses protect mice from heterologous challenge with the highly virulent strains of tick-borne encephalitis virus.
Pletnev AG; Karganova GG; Dzhivanyan TI; Lashkevich VA; Bray M
Virology; 2000 Aug; 274(1):26-31. PubMed ID: 10936085
[TBL] [Abstract][Full Text] [Related]
19. A Fatal Case of Louping-ill in a Dog: Immunolocalization and Full Genome Sequencing of the Virus.
Dagleish MP; Clark JJ; Robson C; Tucker M; Orton RJ; Rocchi MS
J Comp Pathol; 2018 Nov; 165():23-32. PubMed ID: 30502792
[TBL] [Abstract][Full Text] [Related]
20. Protection against European isolates of tick-borne encephalitis virus after vaccination with a new tick-borne encephalitis vaccine.
Klockmann U; Krivanec K; Stephenson JR; Hilfenhaus J
Vaccine; 1991 Mar; 9(3):210-2. PubMed ID: 2042394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
